Advertisement
MCP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/mcp.M600419-MCP200 on February 21, 2007.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
M600419-MCP200v1
6/6/973    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Glossary
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Birrell, G. W.
Right arrow Articles by Lavin, M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Birrell, G. W.
Right arrow Articles by Lavin, M. F.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Molecular & Cellular Proteomics 6:973-986, 2007.
© 2007 by The American Society for Biochemistry and Molecular Biology, Inc.


Research

The Diversity of Bioactive Proteins in Australian Snake Venoms*,S

Geoff W. Birrell{ddagger},§, Stephen T. H. Earl{ddagger},§, Tristan P. Wallis{ddagger},||,**, Paul P. Masci{ddagger}{ddagger}, John de Jersey§§, Jeffrey J. Gorman{ddagger},||,** and Martin F. Lavin{ddagger},§,¶¶

From {ddagger} The Queensland Institute of Medical Research, P. O. Royal Brisbane Hospital, Brisbane 4029, Australia and the § Central Clinical Division and {ddagger}{ddagger} Southern Clinical Division, Faculty of Health Sciences, || Institute for Molecular Biosciences, and §§ School of Molecular and Microbial Sciences, University of Queensland, Brisbane 4072, Australia

Australian elapid snakes are among the most venomous in the world. Their venoms contain multiple components that target blood hemostasis, neuromuscular signaling, and the cardiovascular system. We describe here a comprehensive approach to separation and identification of the venom proteins from 18 of these snake species, representing nine genera. The venom protein components were separated by two-dimensional PAGE and identified using mass spectrometry and de novo peptide sequencing. The venoms are complex mixtures showing up to 200 protein spots varying in size from <7 to over 150 kDa and in pI from 3 to >10. These include many proteins identified previously in Australian snake venoms, homologs identified in other snake species, and some novel proteins. In many cases multiple trains of spots were typically observed in the higher molecular mass range (>20 kDa) (indicative of post-translational modification). Venom proteins and their post-translational modifications were characterized using specific antibodies, phosphoprotein- and glycoprotein-specific stains, enzymatic digestion, lectin binding, and antivenom reactivity. In the lower molecular weight range, several proteins were identified, but the predominant species were phospholipase A2 and {alpha}-neurotoxins, both represented by different sequence variants. The higher molecular weight range contained proteases, nucleotidases, oxidases, and homologs of mammalian coagulation factors. This information together with the identification of several novel proteins (metalloproteinases, vespryns, phospholipase A2 inhibitors, protein-disulfide isomerase, 5'-nucleotidases, cysteine-rich secreted proteins, C-type lectins, and acetylcholinesterases) aids in understanding the lethal mechanisms of elapid snake venoms and represents a valuable resource for future development of novel human therapeutics.


¶¶ To whom correspondence should be addressed: The Queensland Cancer Fund Research Unit, The Queensland Inst. of Medical Research, P. O. Box Royal Brisbane Hospital, Herston, Brisbane 4029, Australia. Tel.: 617-3362-0341; Fax: 617-3362-0106; E-mail: martin.lavin{at}qimr.edu.au


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Hum Mol GenetHome page
A. Suraweera, Y. Lim, R. Woods, G. W. Birrell, T. Nasim, O. J. Becherel, and M. F. Lavin
Functional role for senataxin, defective in ataxia oculomotor apraxia type 2, in transcriptional regulation
Hum. Mol. Genet., September 15, 2009; 18(18): 3384 - 3396.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
J. A. Galan, M. Guo, E. E. Sanchez, E. Cantu, A. Rodriguez-Acosta, J. C. Perez, and W. A. Tao
Quantitative Analysis of Snake Venoms Using Soluble Polymer-based Isotope Labeling
Mol. Cell. Proteomics, April 1, 2008; 7(4): 785 - 799.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement